Cover Image
市場調查報告書

未分化甲狀腺癌:全球臨床實驗趨勢

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 328410
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
未分化甲狀腺癌:全球臨床實驗趨勢 Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 80 Pages
簡介

本報告提供全球的未分化甲狀腺癌治療藥臨床實驗相關調查,提供您各地區的臨床試驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷 (暫時停止、廢止、停止) 的實驗清單等資訊。

簡介

  • 未分化甲狀腺癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上,未分化甲狀腺癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上,未分化甲狀腺癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

未分化甲狀腺癌治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • OXiGENE, Inc.
    • Bayer AG
    • Eisai
    • 第一三共
    • GlaxoSmithKline plc
    • Genelux Corporation
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Case Comprehensive Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
    • University of Schleswig-Holstein
    • University of Colorado
    • University of Michigan Comprehensive Cancer Center
    • University of Kentucky
    • Leiden University Medical Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2582CTIDB

GlobalData's clinical trial report, "Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Anaplastic Thyroid Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Anaplastic Thyroid Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • OXiGENE, Inc.
      • Clinical Trial Overview of OXiGENE, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Genelux Corporation
      • Clinical Trial Overview of Genelux Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
      • Clinical Trial Overview of Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
      • University of Schleswig-Holstein
      • Clinical Trial Overview of University of Schleswig-Holstein
      • University of Colorado
      • Clinical Trial Overview of University of Colorado
      • University of Michigan Comprehensive Cancer Center
      • Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genelux Corporation, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*

List of Figures

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top